期刊
NANOMEDICINE
卷 11, 期 9, 页码 1123-1138出版社
FUTURE MEDICINE LTD
DOI: 10.2217/nnm.16.32
关键词
biomaterial; cationic polymer; chronic myeloid leukemia; drug sensitivity; fibronectin; molecule grafting; polyethylenimine; siRNA delivery; surface modification; transfection
资金
- Alberta Innovates Health Solutions (AIHS)
- Natural Sciences and Engineering Council of Canada (NSERC)
- University of Alberta
- NSERC CREATE Program of Regenerative Medicine
- Alberta Innovates Health Solutions
- Alberta Innovates [201400347] Funding Source: researchfish
Aim: This study aimed to create fibronectin (FN)-grafted polymeric surfaces to investigate the influence of leukemic cell adhesion on siRNA treatment. Materials & methods: FN was grafted on plasma-treated PTFE surfaces using chemical crosslinkers. Adhesion and growth of chronic myeloid leukemia K562 cells on modified surfaces were investigated. The silencing effect of siRNA/lipid-polymers nanoparticles on cells grown on FN-grafted surfaces was evaluated. Results: Crosslinker-mediated immobilization showed significant FN grafting on surfaces, which provided K562 cell adhesion and growth advantage. siRNA nanoparticle silencing was similarly effective on FN-adhered and suspension-growing K562 cells. Conclusion: This study provided initial data to develop a cell-adhesive system to investigate therapeutic effects on leukemic cells. The response of chronic myeloid leukemia cells to siRNA nanoparticles was independent on cell attachment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据